We are live on ! Find out more
Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Portfolio holdings

AUM $34B
1-Year Est. Return 6.31%
This Fund
S&P 500
This Quarter Est. Return
-10.21%
1 Year Est. Return
+6.31%
3 Year Est. Return
+45.79%
5 Year Est. Return
+60.99%
10 Year Est. Return
+604.27%
AUM
$37.6B
AUM Growth
-$5.8B
Cap. Flow
-$178M
Cap. Flow %
-0.47%
Top 10 Hldgs %
18.46%
Holding
738
New
79
Increased
223
Reduced
233
Closed
75

Top Buys

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$199M
2
EXPO icon
Exponent
EXPO
+$135M
3
BANF icon
BancFirst
BANF
+$95.3M
4
BSY icon
Bentley Systems
BSY
+$93.9M
5
TDY icon
Teledyne Technologies
TDY
+$87.7M

Top Sells

Rank Stock Value
1
MSCI icon
MSCI
MSCI
+$426M
2
CDW icon
CDW
CDW
+$239M
3
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
+$135M
4
BILL icon
BILL Holdings
BILL
+$129M
5
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$89.8M

Sector Composition

Rank Sector Weight
1 Industrials 26.1%
2 Technology 21.14%
3 Financials 19.52%
4 Healthcare 9.21%
5 Consumer Discretionary 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
601
Regeneron Pharmaceuticals
REGN
$82.7B
$2K ﹤0.01%
+3
New +$1.9K
RIVN icon
602
Rivian
RIVN
$23B
$2K ﹤0.01%
+40
New +$2.43K
ROK icon
603
Rockwell Automation
ROK
$49.6B
$2K ﹤0.01%
8
– –
RPRX icon
604
Royalty Pharma
RPRX
$26.2B
$2K ﹤0.01%
+54
New +$2.12K
TAK icon
605
Takeda Pharmaceutical
TAK
$55.6B
$2K ﹤0.01%
+108
New +$1.59K
TVTX icon
606
Travere Therapeutics
TVTX
$5.86B
$2K ﹤0.01%
+72
New +$1.91K
UTHR icon
607
United Therapeutics
UTHR
$21.7B
$2K ﹤0.01%
+11
New +$2.1K
ZBH icon
608
Zimmer Biomet
ZBH
$18.9B
$2K ﹤0.01%
12
– –
CTLT
609
DELISTED
CATALENT, INC.
CTLT
$2K ﹤0.01%
+16
New +$1.67K
CERN
610
DELISTED
Cerner Corp
CERN
$2K ﹤0.01%
23
– –
MACK
611
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$2K ﹤0.01%
+300
New +$1.69K
ACAD icon
612
Acadia Pharmaceuticals
ACAD
$5.05B
$1K ﹤0.01%
+55
New +$1.33K
AGZ icon
613
iShares Agency Bond ETF
AGZ
$566M
$1K ﹤0.01%
7
-26
-79% -$2.99K
AKRO
614
DELISTED
Akero Therapeutics
AKRO
$1K ﹤0.01%
+89
New +$1.56K
ALNY icon
615
Alnylam Pharmaceuticals
ALNY
$30.3B
$1K ﹤0.01%
+9
New +$1.37K
AON icon
616
Aon
AON
$74.9B
$1K ﹤0.01%
4
-2
-33% -$582
BCAB icon
617
BioAtla
BCAB
$5.48M
$1K ﹤0.01%
+3
New +$1.25K
BCYC
618
Bicycle Therapeutics
BCYC
$283M
$1K ﹤0.01%
+30
New +$1.4K
BIDU icon
619
Baidu
BIDU
$35.6B
$1K ﹤0.01%
10
– –
BIIB icon
620
Biogen
BIIB
$30.8B
$1K ﹤0.01%
7
-4
-36% -$870
BMEA icon
621
Biomea Fusion
BMEA
$92.8M
$1K ﹤0.01%
+123
New +$798
CNTA
622
DELISTED
Centessa Pharmaceuticals
CNTA
$1K ﹤0.01%
+80
New +$729
COGT icon
623
Cogent Biosciences
COGT
$6.69B
$1K ﹤0.01%
+139
New +$968
COLL icon
624
Collegium Pharmaceutical
COLL
$920M
$1K ﹤0.01%
+71
New +$1.34K
DGX icon
625
Quest Diagnostics
DGX
$26.2B
$1K ﹤0.01%
+8
New +$1.11K
23 24
25
26 27

Similar funds

VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Kayne Anderson Rudnick Investment Management held 738 positions worth $37.6B, down 13% from $43.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Kayne Anderson Rudnick Investment Management's Q1 2022 filing shows 79 new, 223 increased, 233 reduced and 75 closed positions. Its largest new stake was Roblox: 615,038 shares worth $28.4M. The largest sale was MSCI, an estimated $426M.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 26% a quarter earlier, followed by Technology and Financials.

  • Kayne Anderson Rudnick Investment Management's largest Q1 2022 buy was Roblox: 615,038 shares worth $28.4M.
  • Kayne Anderson Rudnick Investment Management added most to Watsco Inc in Q1 2022, an estimated $199M increase.
  • Kayne Anderson Rudnick Investment Management's biggest Q1 2022 reduction was MSCI, cutting an estimated $426M.
  • Kayne Anderson Rudnick Investment Management fully exited Dynatrace in Q1 2022, selling an estimated $52M.
  • Kayne Anderson Rudnick Investment Management's ten largest holdings make up 18% of its $37.6B portfolio in Q1 2022.
  • Kayne Anderson Rudnick Investment Management opened 79 new positions and closed 75 in Q1 2022.
  • Kayne Anderson Rudnick Investment Management's portfolio value fell 13% quarter-over-quarter to $37.6B.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2022, filed 16 May 2022.